We focus on a number of topic areas identified by state health policy leaders as important to population health.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
September 2016 (Volume 94)
September 2016| Joshua M. Sharfstein , | Op-Ed
Every year since 1976, Lake Superior State University in Sault Ste. Marie, Michigan, has released a list of banished words—terms in the English language that deserve never to be spoken again. The university’s 2016 list includes “stakeholder.”1 As one nominator put it, referring to the vampire fighter from Dracula, “Dr. Van Helsing should be the only stake holder.”
In the world of health policy, stakeholders abound. The Centers for Disease Control and Prevention notes that stakeholders can be
Soon after this year’s “banished words” list appeared, AcademyHealth convened a meeting “to bring together a diverse group of stakeholders to review and discuss policy priorities at the forefront of child health.” The US Department of Health and Human Services then promoted the National Health IT Stakeholder Pledge and the National Stakeholder Strategy for Achieving Health Equity. The HealthCare Institute of New Jersey convened the New Jersey Healthcare Stakeholders Summit, and the California Department of Public Health published The Stakeholder Brief.
These organizations—and many, many more—use the term “stakeholder” to express themeaning of “one who is involved in or affected by a course of action,” the third listed definition inMerriam-Webster’s online dictionary (http://www.merriam-webster.com/dictionary/stakeholder). An agency “reaches out to,” “includes,” “engages with,” or otherwise “hears from” stakeholders to develop health policies that will work in the real world.
I understand the utility of a shorthand term to signify that policies are not being made in a bubble. But I stand with Lake Superior State University: The term “stakeholder” should be relegated to the same linguistic storage facility as “trepanation” and “orgone generator.”
To start, “stakeholder” has a mercenary connotation. The original meaning of the term is a person who literally held the money of bettors while the game was on. This meaning evolved into a second definition: “a person, company, etc., with a concern or (esp. financial) interest in ensuring the success of an organization, business, system, etc.”3
Such a word origin is especially curious when it comes to health policy because stakeholders, in fact, frequently do have financial interests in the issue at hand. Depending on the matter, “key stakeholders” may include hospitals, physician practices, pharmaceutical companies, long-term care facilities, managed care organizations, insurers, and health IT companies.
It is, of course, essential to listen to the perspectives of those whose bottom line is affected by regulation and policy, but a catchall phrase like “stakeholder” obscures the landscape in question, much like a dense fog. Consider the greater clarity achieved by changing the sentence “Medicare proposed cutting the reimbursement rate to $2,500 per procedure, but there is significant pushback from stakeholders” to “Medicare proposed cutting the reimbursement rate to $2,500 per procedure, but those whose rates would be cut are protesting.”
As a business term, “stakeholder” carries an assumption that all stakes have equivalent intrinsic merit. There are strategies to “identify key stakeholders,” books on and courses in “stakeholder management,” and videos on how to “deal with angry stakeholders.” A primary goal of this enterprise is to “make the stakeholders happy.”
The purpose of good health policy, however, is not to make the stakeholders happy. Instead, the purpose is to advance the health of the public at reasonable cost. Sadly, a number of health regulations and payment policies include provisions that favor financially interested parties with negative or no benefit for the public at large. “Stakeholder engagement” can put such interested parties on the same level as the many individuals and families who pay more, suffer worse quality of care, or go without key preventive interventions. In essence, in a world where everyone is a “stakeholder,” there is less room for the public interest.
Those who are skeptical of my concern over this terminology ought to attend a few more “stakeholder meetings.” Many are filled with lobbyists whose job it is to restate established positions of industries or organizations, with little opportunity for give-and-take. Stakeholder meetings can last for hours and include dozens of people, some of whom have tussled and fought with one another for years.
A collection of “stakeholder meetings” is called a “stakeholder committee.” Over many hours of debate and discussion, entrenched interests often take the opportunity to dig in deeper. I recently attended a meeting on hospital finance that one participant ruefully described as the 28th on the topic before restating his organization’s same position from the beginning.
In place of unwieldy stakeholder committees, government agencies should convene smaller advisory committees with a specific charge and timeline. Such committees should hold public meetings and take public comment. The committees can ask those with special expertise, unique experiences, and even financial interest to provide input not only on the problem but also on creative solutions. Moreover, these committees can respond thoughtfully to all perspectives raised before making clearly understood recommendations that serve the common good.
This is hardly a new idea. For example, in October 1927, the Committee to Study and Report on Advisory Committees for Official Public Health Nursing presented its findings at the American Public Health Association meeting in Cincinnati, Ohio. The committee noted that the best advice comes from individuals who “serve without pay” and “represent no partisan politics nor self-seeking interests in the community” and who should “be chosen for their intelligence, public spirit, generally known integrity and good will.”4
Recently, the state of Rhode Island asked a small group of experts to engage in extensive public consultation on the challenge of addiction and to make a set of strategic recommendations. At an early public meeting, Dr. Josiah Rich of Brown Alpert Medical School announced, “Our goal here is not to make everybody in this room happy. Our goal is to cut down on overdose deaths.”5
With regard to the many stakeholder sessions already being planned for 2017, it’s not too late to break out the dictionary and use more specific and helpful terms. Agencies should also consider whether a neutral expert committee should be added to the policymaking mix. One can only hope that within a year or two, we all might be working together on banishing other phrases listed by Lake Superior State University from the health policy lexicon, including “community of learners,” “factoid,” and “kick the can down the road.”
Author(s): Joshua M. Sharfstein
Read on Wiley Online Library
Volume 94, Issue 3 (pages 476–479) DOI: 10.1111/1468-0009.12208 Published in 2016
Joshua M. Sharfstein is associate dean for public health practice and training at the Johns Hopkins Bloomberg School of Public Health. He served as secretary of the Maryland Department of Health and Mental Hygiene from 2011 to 2014, as principal deputy commissioner of the US Food and Drug Administration from 2009 to 2011, and as the commissioner of health in Baltimore, Maryland, from December 2005 to March 2009. From July 2001 to December 2005, Sharfstein served on the minority staff of the Committee on Government Reform of the US House of Representatives, working for Congressman Henry A. Waxman. He serves on the Board on Population Health and Public Health Practice of the Institute of Medicine and the editorial board of JAMA. He is a 1991 graduate of Harvard College, a 1996 graduate of Harvard Medical School, a 1999 graduate of the combined residency program in pediatrics at Boston Medical Center and Boston Children’s Hospital, and a 2001 graduate of the fellowship program in general pediatrics at the Boston University School of Medicine.
“Big Food” Is Making America Sick
How Might Democrats Try to Improve and Expand the ACA in 2017?
Get the Latest from the Milbank Memorial Fund